Hajdara, A.; Çakır, U.; Érsek, B.; Silló, P.; Széky, B.; Barna, G.; Faqi, S.; Gyöngy, M.; Kárpáti, S.; Németh, K.;
et al. Targeting Melanoma-Associated Fibroblasts (MAFs) with Activated γδ (Vδ2) T Cells: An In Vitro Cytotoxicity Model. Int. J. Mol. Sci. 2023, 24, 12893.
https://doi.org/10.3390/ijms241612893
AMA Style
Hajdara A, Çakır U, Érsek B, Silló P, Széky B, Barna G, Faqi S, Gyöngy M, Kárpáti S, Németh K,
et al. Targeting Melanoma-Associated Fibroblasts (MAFs) with Activated γδ (Vδ2) T Cells: An In Vitro Cytotoxicity Model. International Journal of Molecular Sciences. 2023; 24(16):12893.
https://doi.org/10.3390/ijms241612893
Chicago/Turabian Style
Hajdara, Anna, Uğur Çakır, Barbara Érsek, Pálma Silló, Balázs Széky, Gábor Barna, Shaaban Faqi, Miklós Gyöngy, Sarolta Kárpáti, Krisztián Németh,
and et al. 2023. "Targeting Melanoma-Associated Fibroblasts (MAFs) with Activated γδ (Vδ2) T Cells: An In Vitro Cytotoxicity Model" International Journal of Molecular Sciences 24, no. 16: 12893.
https://doi.org/10.3390/ijms241612893
APA Style
Hajdara, A., Çakır, U., Érsek, B., Silló, P., Széky, B., Barna, G., Faqi, S., Gyöngy, M., Kárpáti, S., Németh, K., & Mayer, B.
(2023). Targeting Melanoma-Associated Fibroblasts (MAFs) with Activated γδ (Vδ2) T Cells: An In Vitro Cytotoxicity Model. International Journal of Molecular Sciences, 24(16), 12893.
https://doi.org/10.3390/ijms241612893